Spændingen stiger i TEVA
-
Op til weekendens udmelding fra FDA er der spænding for TEVA-aktionærerne.
Her kigger jeg lige på aktien ud fra TA-perspektiv og fortæller, om jeg mener TA kan bruges til noget i denne sammenhæng -
TEVA fik godkendelsen fra FDA.
-
Det bliver en buy-the-rumors-sell-the-fact event...Short time oppe med 5-10%. Derefter tilbagefalde i niveauet 21-23 igen....Det bliver et godt Swing play
-
8% oppe i Israel.
-
TEVA kan få det svært på migrænemarkedet:
Migraine market starts to look tough for Teva
The enthusiasm over FDA approval for Teva's migraine treatment has waned.
(en.globes.co.il)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind